Literature DB >> 1851533

Poxvirus pathogenesis.

R M Buller1, G J Palumbo.   

Abstract

Poxviruses are a highly successful family of pathogens, with variola virus, the causative agent of smallpox, being the most notable member. Poxviruses are unique among animal viruses in several respects. First, owing to the cytoplasmic site of virus replication, the virus encodes many enzymes required either for macromolecular precursor pool regulation or for biosynthetic processes. Second, these viruses have a very complex morphogenesis, which involves the de novo synthesis of virus-specific membranes and inclusion bodies. Third, and perhaps most surprising of all, the genomes of these viruses encode many proteins which interact with host processes at both the cellular and systemic levels. For example, a viral homolog of epidermal growth factor is active in vaccinia virus infections of cultured cells, rabbits, and mice. At least five virus proteins with homology to the serine protease inhibitor family have been identified and one, a 38-kDa protein encoded by cowpox virus, is thought to block a host pathway for generating a chemotactic substance. Finally, a protein which has homology with complement components interferes with the activation of the classical complement pathway. Poxviruses infect their hosts by all possible routes: through the skin by mechanical means (e.g., molluscum contagiosum infections of humans), via the respiratory tract (e.g., variola virus infections of humans), or by the oral route (e.g., ectromelia virus infection of the mouse). Poxvirus infections, in general, are acute, with no strong evidence for latent, persistent, or chronic infections. They can be localized or systemic. Ectromelia virus infection of the laboratory mouse can be systemic but inapparent with no mortality and little morbidity, or highly lethal with death in 10 days. On the other hand, molluscum contagiosum virus replicates only in the stratum spinosum of the human epidermis, with little or no involvement of the dermis, and does not spread systemically from the site of infection. The host response to infection is progressive and multifactorial. Early in the infection process, interferons, the alternative pathway of complement activation, inflammatory cells, and natural killer cells may contribute to slowing the spread of the infection. The cell-mediated response involving learned cytotoxic T lymphocytes and delayed-type hypersensitivity components appears to be the most important in recovery from infection. A significant role for specific antiviral antibody and antibody-dependent cell-mediated cytotoxicity has yet to be demonstrated in recovery from a primary infection, but these responses are thought to be important in preventing reinfection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851533      PMCID: PMC372802          DOI: 10.1128/mr.55.1.80-122.1991

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  449 in total

1.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  Differential inhibitory effects of interferon on deoxythymidine kinase induction of vaccinia-infected cell cultures.

Authors:  S Barban; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

3.  The role of the major histocompatibility complex in the adoptive transfer of ectromelia virus meningitis.

Authors:  M L Berger
Journal:  J Neuropathol Exp Neurol       Date:  1982-01       Impact factor: 3.685

4.  Intragenomic sequence transposition in monkeypox virus.

Authors:  J J Esposito; C D Cabradilla; J H Nakano; J F Obijeski
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

5.  Analysis of Yaba tumor poxvirus-induced proteins in infected cells by two-dimensional gel electrophoresis.

Authors:  A Vafai; H Rouhandeh
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

6.  Malignant rabbit fibroma virus causes secondary immunosuppression in rabbits.

Authors:  D S Strayer; E Skaletsky; G F Cabirac; P A Sharp; L B Corbeil; S Sell; J L Leibowitz
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Abortive replication of vaccinia virus in activated rabbit macrophages.

Authors:  N A Buchmeier; S R Gee; F A Murphy; W E Rawls
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

8.  Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.

Authors:  L G Payne
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

9.  Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.

Authors:  D S Strayer; S Sell
Journal:  J Natl Cancer Inst       Date:  1983-07       Impact factor: 13.506

10.  Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.

Authors:  D A Cohen; H C Bubel
Journal:  J Reticuloendothel Soc       Date:  1983-01
View more
  149 in total

1.  Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.

Authors:  Min Fang; Nicholas A Siciliano; Adam R Hersperger; Felicia Roscoe; Angela Hu; Xueying Ma; Ahamed R Shamsedeen; Laurence C Eisenlohr; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Authors:  L N Klapper; S Glathe; N Vaisman; N E Hynes; G C Andrews; M Sela; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Authors:  Ann L Oberg; Neelam Dhiman; Diane E Grill; Jenna E Ryan; Richard B Kennedy; Gregory A Poland
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

4.  Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.

Authors:  Liang-Chuan S Wang; Rachel C Lynn; Guanjun Cheng; Edward Alexander; Veena Kapoor; Edmund K Moon; Jing Sun; Zvi G Fridlender; Stuart N Isaacs; Stephen H Thorne; Steven M Albelda
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

6.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 7.  Interventions for cutaneous molluscum contagiosum.

Authors:  Johannes C van der Wouden; Renske van der Sande; Emma J Kruithof; Annet Sollie; Lisette Wa van Suijlekom-Smit; Sander Koning
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

8.  Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.

Authors:  D G Brownstein; L Gras
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Importance of interferons in recovery from mousepox.

Authors:  G Karupiah; T N Fredrickson; K L Holmes; L H Khairallah; R M Buller
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice.

Authors:  A V Atrasheuskaya; E K Bukin; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.